Tag: CEO
Teva CEO Schultz took a big pay cut last year—but he...
Teva has undergone a massive transformation in the past two years after a $3 billion restructuring fundamentally reshaped the Israeli drugmaker's operations. The man...
‘Boring is good,’ Teva CEO Schultz says amid push to hit...
Teva’s CEO Kåre Schultz had his hands full when he joined the company back in 2017, and while the drugmaker still faces significant challenges, he's...
Teva CEO says manufacturing cuts will keep coming even after $3B...
The way Teva Pharmaceutical CEO Kåre Schultz figures it, manufacturing is the cost-cutting gift that just keeps on giving. After the Israeli drugmaker completes...
Teva CEO Kåre Schultz nabs whopping $33M in first full year...
If you thought Teva had gone big-time with its 2017 pay package for CEO Kåre Schultz, check out what it paid him in 2018.
The...
Teva’s escaped the generics ‘death spiral,’ but it can’t take all...
SAN FRANCISCO—A year ago at the J.P. Morgan Healthcare Conference, new Teva CEO Kåre Schultz detailed his plan to get the struggling drugmaker back...
Want a glimpse into pharma’s future? Look to cable television, Merck...
If all the scrutiny on drug prices has taught us anything, it's that there are a lot of intermediate players in today’s pharma supply...
